A new study published in the journal Scientific Reports, and published online by the National Institute of Health, has found that activation of the CB2 receptor – done naturally through the consumption of cannabis – can protect against liver inflammation and disease caused by alcohol.
For the study, researchers used mice with alcohol-induced live disease, and administered a cannabinoid receptor agonist (meant to mimic the effects of cannabis) to a portion of them.
They found that the agonist “protected from alcohol-induced liver inflammation and steatosis [fatty liver disease] in wild-type mice”.
The study concludes; “Altogether these results demonstrate that CB2 receptor activation in macrophages protects from alcohol-induced steatosis by inhibiting hepatic inflammation through an autophagy-dependent pathway.”
You can find the full study by clicking here.